Covid-19 Scenario:
- Due to the outbreak of the COVID-19 pandemic in 2020, there was a little slowdown in the market for allergy diagnostics, as diagnostic tests were being postponed due to lockdown scenarios.
- However, in 2021, the diagnostic processes resumed. To determine the impact of COVID-19 on allergy diagnostic testing services, several research had been done.
- According to a survey done in Turkey, allergists preferred telemedicine for treating asthma and rhinitis at a high rate. For more serious allergic conditions, such as anaphylaxis and hereditary angioedema, face-to-face interviews were recommended.
- Other nations such as Italy and the U.S. also showed a similar tendency. Australia reduced the number of outpatient clinic face-to-face consultations for urgent patients with rheumatological disorders and switched approximately 80% of outpatient visits to telemedicine.
- The expansion of the market was also constrained by this restriction and a decrease in different diagnostic and treatment services.
According to the report published by Allied Market Research, The global Allergy Diagnostics Market Size was valued at USD 5.0 billion in 2021, and it is estimated to surpass around USD 16.7 billion by 2031, with a registered CAGR of 13.2% during the period 2022-2031.
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/860
Allergy Diagnostics Companies:-
• Alerchek Inc.
• Danaher Corp
• Hitachi chemical Diagnostic Inc
• HOB Biotech Group Co. Ltd
• Hycor Biomedical Inc.
• Lincoln Diagnostics Inc.
• Omega Diagnostic Llc
• Siemens Healthcare Diagnostics, Inc.
• Stallergenes SA
• Thermo Fisher Scientific Inc.
• Thermo Fisher Scientific Inc.
• Danaher
• Omega Diagnostics Group PLC
• Eurofins Scientific
• bioMérieux SA
• HollisterStier Allergy
• Minaris Medical America, Inc.
• ACON Laboratories, Inc.
• Lincoln Diagnostics, Inc.
• Neogen Corporation
Global Allergy Diagnostics Market Segmentation: –
Based on test type, the in vivo segment held the highest share in 2021, accounting for more than half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. However, the in vitro segment is expected to register the highest CAGR of 13.5% from 2022 to 2031.
Based on product & service, the consumables segment accounted for the highest share in 2021, contributing to around half of the global allergy diagnostics market, and is expected to maintain its lead in terms of revenue during the forecast period. Moreover, the same segment is expected to manifest the highest CAGR of 13.6% from 2022 to 2031.
Based on end user, the diagnostic laboratories segment accounted for the highest share in 2021, holding nearly half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is estimated to grow at the highest CAGR of 13.7% during the forecast period.
Based on region, North America held the largest share in 2021, contributing to around one-third of the total allergy diagnostics market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 14.2% during the forecast period. The research also analyzes regions including Europe and LAMEA.
Surge in respiratory diseases due to exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution serves as a potential opportunity for the expansion of the global allergy diagnostics market
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/860
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in the coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/connect-to-analyst/860
Other Trending Report:
- Healthcare IT Market
- Rheumatoid Arthritis Drugs Market
- Proteomics Market
- Medical Device Affairs Outsourcing Market
Other Trending Report:
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.